Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oregon for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oregon only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oregon (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Robert Beardsley (NPI 1437302825)

Field	Value
Entity Type	Individual
Organization	Robert Beardsley
Address	1550 Oak St
City	Eugene
State	OR
ZIP	97401
Taxonomy	Ophthalmology Physician
NPI Enumerated	October 29, 2008

Payer Source	Total Paid
Medicare	$3.3M
Medicaid	$0

Key Findings

This provider’s revenue is effectively single-payer: total Medicare revenue is $3.3M and there is no Medicaid billing on file, which means the practice’s public-payer footprint is concentrated almost entirely in Medicare rather than a mixed Medicare/Medicaid payer mix. That concentration will focus commercial and Medicare contract negotiations and utilization reviews on the same patient population and service set.

Revenue is highly concentrated in a few drug codes: the precomputed top 3 Medicare codes account for 76.9% of total Medicare revenue, driven by J0178 at 50.9%, J2777 at 17.8%, and J3490 at 8.1%. This concentration indicates that a small set of injectable therapies and unclassified drug billing represent the dominant portion of the practice’s Medicare receipts.

The code mix points to an office-based retina/intravitreal therapy practice: high revenue from J0178 and J2777 and procedural volume for 67028 reflect repeated intravitreal drug administration, while codes such as J2781, 67042, and J67036 indicate additional intravitreal and surgical retina activity. The presence of substantial imaging (92134) and frequent E/M (99214/99213) billing further supports a model built around recurring injections with imaging-guided follow-up visits.

Competitive standing on the principal drug codes is above average but not uniquely dominant: J0178 ranks #332 of 3204 providers (90th percentile; typical, unremarkable volume), J2777 ranks #511 of 2039 providers (75th percentile; typical, unremarkable volume), and J3490 ranks #457 of 2838 providers (84th percentile; typical, unremarkable volume). In short, the provider is a meaningful regional user of these medications relative to peers, but the national ranks suggest typical rather than market-leading scale for anti-VEGF utilization.

Diagnostic imaging and visit volumes are extreme relative to peers: 92134 shows 3.1K claims and $89.1K revenue (2.7%) and ranks #370 of 26868 providers (99th percentile; extreme outlier), while 99214 (938 claims, $86.3K, 2.6%) ranks #13419 of 479517 providers (97th percentile; notably above typical) and 99213 (954 claims, $58.2K, 1.7%) ranks #7211 of 457151 providers (98th percentile; extreme outlier). These patterns are consistent with a high-throughput retinal clinic that pairs frequent imaging with repeated follow-up visits and injection scheduling.

Procedural coding also supports high injection throughput: 67028 shows 2.1K claims and $202.8K revenue (6.1%) and ranks #345 of 4255 providers (92th percentile; notably above typical national volume for this code). The combination of high 67028 procedural volume with dominant anti-VEGF drug revenue underscores an operational focus on recurring injection procedures as a primary service line.

Use of newer or specialized intravitreal agents is notable: J2781 (pegcetacoplan) accounts for $181.8K (5.5%) with 1.5K claims and ranks #43 of 490 providers (91th percentile; typical, unremarkable volume), indicating adoption of additional intravitreal therapeutics beyond traditional anti-VEGF agents. This suggests the practice treats a range of retinal conditions and may provide therapeutics positioned for different retinal disease indications.

The provider is an established practitioner with long tenure: NPI enumerated 2008-10-29 (~18 years ago), which supports interpretation of the billing pattern as the output of a mature practice rather than a new entrant. That tenure, combined with concentrated Medicare revenue and high imaging and E/M throughput, implies an entrenched local retina practice reliant on Medicare payer flows and repeat-treatment service lines.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

20 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,470	$690	$1.7M
J2777	Injection, faricimab‑svoa, 0.1 mg	20,460	$30	$593.3K
J3490	Unclassified drugs	150	$1,760	$268.7K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,110	$100	$202.8K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	1,520	$120	$181.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,070	$30	$89.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	940	$90	$86.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	950	$60	$58.2K
J7999	Compounded drug, not otherwise classified	720	$70	$48.4K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	210	$150	$31.9K

Showing 1–10 of 20

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oregon Distribution

Robert Beardsley — 5 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oregon

Full comparison — all codes billed, vs. state median

20 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	2	60	840	$680	$623.7K
J2777	6	30	10,050	$30	$527.6K
J2781	2	10	690	$120	$102.6K
67028	3	70	580	$90	$72.3K
J7312	5	10	300	$150	$47.7K
J3490	7	50	40	$640	$42.9K
67036	11	10	30	$1,000	$29K
67042	3	10	20	$1,100	$27.5K
J7999	5	50	270	$70	$23.4K
92235	9	30	60	$100	$11.1K

Showing 1–10 of 20

Related Providers

Other providers that share a Tax Identification Number (TIN) with Robert Beardsley, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Fairview Health Services	MN	General Acute Care Hospital	$0	$90.4M
Regions Hospital	MN	General Acute Care Hospital	$0	$44.4M
Fairview Express Care	MN	Specialist	$0	$33.1M
Fairview Health Services	MN	General Acute Care Hospital	$0	$30M
Fairview Health Services	MN	Emergency Medicine Physician	$0	$26.6M
Fairview Health Services	MN	General Acute Care Hospital	$0	$17.2M
Regions Hospital	MN	Emergency Medicine Physician	$0	$15.1M
Fairview Express Care	MN	General Practice Physician	$0	$11.4M
Oregon Eye Consultants LLC	OR	Ophthalmology Physician	$0	$9.6M
Maple Grove Hospital Corporation	MN	General Acute Care Hospital	$0	$7.6M

Nearby Providers

Other providers in the same ZIP code as Robert Beardsley, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Peacehealth Medical Group	OR	Family Medicine Physician	$0	$45.3M
Options Counseling Services Of Oregon	OR	Mental Health Counselor	$0	$25.9M
Eugene Emergency Physicians PC	OR	Emergency Medicine Physician	$0	$16.9M
Center For Family Development, Inc.	OR	Mental Health Counselor	$0	$15.6M
Laurel Hill Center	OR	Eyewear Supplier	$0	$14M
Looking Glass Community Services	OR	Mental Health Counselor	$0	$13.5M
Peacehealth	OR	General Acute Care Hospital	$0	$13.3M
Addiction Counseling And Education Services Inc.	OR	Mental Health Counselor	$0	$12.8M
Ch Mh Services (or), LLC	OR	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$9.4M
Oregon Healthcare Resources, LLC	OR	Multi-Specialty Clinic/Center	$0	$8.8M

Robert Beardsley — Billing Profile & Reimbursement Data

Sign up for Robert Beardsley — Billing Profile & Reimbursement Data policy alerts

Robert Beardsley — Billing Profile & Reimbursement Data

Sign up for Robert Beardsley — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References